Moleculin Biotech Inc. filed SEC Form 8-K: Other Events

false 0001659617 0001659617 2025-04-09 2025-04-09

 

 

 

 

 

 

 

 

 

(Exact Name of Registrant as Specified in its Charter)

 

 

(Address of principal executive offices and zip code)

 

(Registrant’s telephone number, including area code)

(Former name or former address, if changed from last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).                                    Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

 

Item 8.01. Other Events.

 

Moleculin Biotech Inc., (the “Company”) convened its Special Meeting of Stockholders (the “Special Meeting”) at the Company’s offices located at 5300 Memorial Drive, Suite 950, Houston, Texas 77007, on April 9, 2025, at 10:00 a.m. Central Time. After counting the number of shares present in person and by proxy, it was determined that a quorum for the transaction of business at the Special Meeting was not present. A vote of shares present was held to adjourn the Special Meeting until April 25, 2025, at 10:00 a.m. Central Time, at the Company’s offices located at 5300 Memorial Drive, Suite 950, Houston, Texas 77007.

 

Therefore, the Special Meeting has been adjourned until April 25, 2025, at 10:00 a.m. Central Time, at the Company’s offices located at 5300 Memorial Drive, Suite 950, Houston, Texas 77007. All business to be transacted at the Special Meeting remains the same.

 

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.